Medtronic
 
 

Medtronic
Vision 3D™
Portfolio

MVP® — Managed Ventricular Pacing

MVP® —Managed Ventricular Pacing
Reduces unnecessary RV pacing by 99%*1
(dual chamber only)

Why is it critical to pace less?

AHA Science Advisory:
For patients who need pacing, efforts should be made to program the device to minimize the amount of ventricular pacing when AV conduction is intact.2

Unnecessary RV pacing increases risk3-5 of:

  • Atrial fibrillation (AF)
  • Heart failure hospitalization (HFH)
  • Mortality

Every incremental 1% of unnecessary RV pacing increases the risk of AF by 1% and risk of HFH by 5.4%3

MOST Sub-Study

SAVE-PACe Study

 

SAVE-PACe Study

MVP® — The New Standard of Pacing

  • Reduces unnecessary RV Pacing by 99%*1
  • Promotes intrinsic conduction
  • Universal pacing mode adapts to patient's needs
  • Operates in AAI(R) mode with the added safety of ventricular back-up pacing when needed.

 


 

*Median

References
  1. Gillis AM, Pürerfellner H, Israel CW, et al. Reduction of unnecessary ventricular pacing due to the Managed Ventricular Pacing (MVP) mode in pacemaker patients: Benefit for both sinus node disease (SND) and AV block (AVB) indications. Heart Rhythm. 2005;Abstract AB21-1.
  2. Knight BP, Gersh BJ, Carlson MD, et al. Role of permanent pacing to prevent atrial fibrillation: Science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation. January 18, 2005;111(2)240-243.
  3. Extrapolated from Sweeney MO, Hellkamp AS, Ellenbogen KA, et al, for the MOde Selection Trial (MOST) Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. June 17, 2003;107(23):2932-2937.
  4. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. December 25, 2002;288(24):3115-3123.
  5. Sweeney MO, Bank AJ, Nsah E, et al. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med. September 6, 2007;357(10):1000-1008.

Part of the Medtronic Vision 3D™ Portfolio